Anti-BAG3 [V65P1E8*D2]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
 - References (0)
 - Inventor Info
 
Info
| Catalogue Number | 152781 | 
| Applications | ELISA IHC WB | 
| Antigen/Gene or Protein Targets | BAG family molecular chaperone regulator 3 | 
| Synonyms | BAG3, Bcl-2-associated athanogene 3, Bcl-2-binding protein Bis, Docking protein CAIR-1 | 
| Reactivity | Human | 
| Relevance | 
                                                                    Anti-BCL2-Associated Athanogene 3 (BAG3) [V65P1E8*D2] is specific for human BAG3.  BAG3 is involved in chaperone-assisted selective autophagy. Inhibits the chaperone activity of HSP70/HSC70 by promoting substrate release. Has anti-apoptotic activity.  In muscle cells, BAG3 cooperates with the molecular chaperones Hsc70 and HspB8 to induce the degradation of mechanically damaged cytoskeleton components in lysosomes. This process is called chaperone-assisted selective autophagy (CASA) and is essential for maintaining muscle activity. Defects in BAG3 are the cause of myopathy myofibrillar BAG3-related (MFM-BAG3) [MIM:612954]. A neuromuscular disorder that results in early-onset, severe, progressive, diffuse muscle weakness associated with cardiomyopathy, severe respiratory insufficiency during adolescence, and a rigid spine in some patients.  | 
                        
| Host | Mouse | 
| Immunogen | Ovalbumin-conjugated synthetic peptide MTDTPGNPAAP | 
| Subclass | IgG1 kappa | 
| Myeloma Used | P3X63Ag8.653 | 
| Strain | Balb/c | 
| Research Area | Apoptosis and Programmed Cell Death, Cancer, Cardiovascular, Metabolism | 
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference